Retractable Technologies (NYSE:RVP) Research Coverage Started at StockNews.com

StockNews.com began coverage on shares of Retractable Technologies (NYSE:RVP) in a research note issued to investors on Saturday. The firm issued a hold rating on the stock.

Retractable Technologies Stock Performance

Retractable Technologies stock opened at $0.72 on Friday. The stock’s 50-day moving average is $0.83 and its 200-day moving average is $0.99. The company has a market cap of $21.58 million, a price-to-earnings ratio of -2.77 and a beta of 2.06. The company has a debt-to-equity ratio of 0.01, a current ratio of 9.51 and a quick ratio of 6.54. Retractable Technologies has a 12 month low of $0.71 and a 12 month high of $1.34.

Retractable Technologies (NYSE:RVP) last announced its earnings results on Wednesday, August 14th. The company reported ($0.48) EPS for the quarter. The company had revenue of $6.03 million for the quarter. Retractable Technologies had a negative net margin of 46.72% and a negative return on equity of 18.67%.

Insider Activity at Retractable Technologies

In other news, CEO Thomas J. Shaw acquired 71,422 shares of the company’s stock in a transaction dated Friday, September 20th. The shares were bought at an average price of $0.82 per share, with a total value of $58,566.04. Following the purchase, the chief executive officer now owns 14,743,907 shares of the company’s stock, valued at approximately $12,090,003.74. This represents a 0.00 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Insiders purchased 198,409 shares of company stock worth $171,498 in the last 90 days. 55.00% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Retractable Technologies

A hedge fund recently bought a new stake in Retractable Technologies stock. PFG Investments LLC purchased a new stake in Retractable Technologies, Inc. (NYSE:RVP) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 34,600 shares of the company’s stock, valued at approximately $27,000. PFG Investments LLC owned 0.12% of Retractable Technologies at the end of the most recent reporting period. Institutional investors own 7.58% of the company’s stock.

About Retractable Technologies

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.